Dysfunctional Telomeres, Checkpoints and Aging
Dysfunctional Telomeres, Checkpoints and Aging
批准号:
7910424
负责人:
Kwok Kin Wong
金额:
$26.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-30 至 2011-08-31
关键词:
AccelerationAgeAgingAging-Related ProcessAllelesApoptosisAutopsyBiologicalBiological ModelsBreedingCell AgingCell Culture TechniquesCell DeathCell divisionCellsChickensChromosomal RearrangementChromosomesComplexDNADataDoctor of MedicineDoctor of PhilosophyEngineeringEventFailureFunctional disorderGene DosageGenerationsGenesGeneticGenomeGenome StabilityGenomic InstabilityGenotypeHistocompatibility TestingHomeostasisIn VitroIncidenceLengthLightLinkLongevityMalignant NeoplasmsModelingMolecularMolecular CytogeneticsMolecular GeneticsMusMutant Strains MiceMutationOrganOrgan failureOxidative StressPathologicPathway interactionsPhenotypePhysiologicalPlayPopulationPremature aging syndromePreventionProcessReadingReserve Stem CellRoleSeriesSignal TransductionStagingStem cellsStructureTP53 geneTamoxifenTelomeraseTelomere MaintenanceTelomere ShorteningTestingTherapeutic InterventionTimeTissuesTumor SuppressionWorkanimal tissuearmbasebeta Actinbody systemcancer genomecarcinogenesiscell typecellular targetingcohortexhaustin vivoinsightmouse modelmutantmutant mouse modelpreventreconstitutionresponsesenescencestemtelomeretumor progressiontumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Telomeres are specialized capping structures on chromosomes that play important roles in aging, cancer and genome stability. With each cell division, telomeres progressively shorten such that upon reaching a critical stage, they signal cells to stop dividing. This process likely prevents cells from acquiring mutations that may result in cancer or aging. When mutations occur in crucial genes that regulate telomere maintenance or checkpoint responses (such as p53 and ATM), telomeres become critically shortened and dysfunctional. Our recent findings linking telomere dysfunction to precursor/stem cell depletion and accelerated aging in the combined telomerase Atm mutant mouse model provide a unique opportunity and genetic platform to explore the molecular mechanisms by which telomere dysfunction contributes to aging, organ homeostasis and tumorigenesis. We hypothesize that mice engineered to have critically short telomeres and defective checkpoint responses due to mTerc and Atm deficiency will be predisposed to either accelerated aging or tumorigenesis depending on p53 status. We also believe that reconstitution of telomerase activity in different organ compartments of these mice will, depending on the state of the genome at the time of the reconstitution, either strongly promote organ specific tumor progression or rescue the organ stem/progenitor cell depletion phenotype as well as suppressing tumorigenesis. Lastly, detailed molecular characterization of pathways leading to activation of p53 function in primary cells and tissues from these compound mutant mice with accelerated aging and precursor/stem cell depletion will dissect the molecular pathways that are involved in the process of aging and organ homeostasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic strategies for specific subsets of KRAS mutant lung cancers
-
批准号:9451116
-
项目类别:
-
资助金额:$55.92万
-
财政年份:2017
-
负责人:Kwok Kin Wong
-
依托单位:
Animal Models/Experimental Therapeutics Core
-
批准号:8237138
-
项目类别:
-
资助金额:$8.71万
-
财政年份:2012
-
负责人:Kwok Kin Wong
-
依托单位:
Core C: Animal Modeling and Preclinical Therapeutics
-
批准号:10231104
-
项目类别:
-
资助金额:$26.38万
-
财政年份:2012
-
负责人:Kwok Kin Wong
-
依托单位:
Dysfunctional Telomeres, Checkpoints and Aging
-
批准号:7653672
-
项目类别:
-
资助金额:$26.99万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8450878
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8826566
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Dysfunctional Telomeres, Checkpoints and Aging
-
批准号:7484951
-
项目类别:
-
资助金额:$27.08万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7428779
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7269241
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7130431
-
项目类别:
-
资助金额:$28.55万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7837568
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7621014
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8640891
-
项目类别:
-
资助金额:$27.38万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Dysfunctional Telomeres, Checkpoints and Aging
-
批准号:7289887
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Dysfunctional Telomeres, Checkpoints and Aging
-
批准号:7065017
-
项目类别:
-
资助金额:$28.63万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8332284
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8108668
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Modeling Lung Cancer in Telomerase Null Mice
-
批准号:6804430
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:Kwok Kin Wong
-
依托单位:
Modeling Lung Cancer in Telomerase Null Mice
-
批准号:6945778
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:Kwok Kin Wong
-
依托单位:
Modeling Lung Cancer in Telomerase Null Mice
-
批准号:6617124
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:Kwok Kin Wong
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: